Related Experiment Video
Updated: Jan 19, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Identification of different clinical faces of obstructive sleep apnea in children
Yunxiao Wu1, Guoshuang Feng2, Zhifei Xu3
1Beijing Key Laboratory of Pediatric Otolaryngology, Head & Neck Surgery, Beijing Pediatric Research Institute, China.
Insights
Children with obstructive sleep apnea syndrome exhibit diverse clinical presentations. Identifying these distinct profiles, like snoring/sleepiness or hyperactivity, aids personalized diagnosis and treatment.
Area of Science:
- Pediatric Sleep Medicine
- Respiratory Medicine
- Clinical Phenotyping
Background:
- Obstructive sleep apnea syndrome (OSAS) in children presents with varied symptoms.
- The apnea-hypopnea index alone is insufficient for predicting clinical phenotypes.
Purpose of the Study:
- To identify and classify the heterogeneity of clinical presentations in pediatric obstructive sleep apnea syndrome.
- To develop a predictive model for distinct OSAS clinical profiles in children.
Main Methods:
- Utilized polysomnography data and a sleep disorder questionnaire for children aged 3-14.
- Employed cluster analysis to categorize patients based on symptoms and comorbidities.
- Developed a prediction model using statistically significant variables.
Main Results:
- Identified three distinct clinical clusters: "nocturnal snoring and daytime sleepiness," "hyperactivity," and "minimally symptomatic."
- The prediction model achieved 86% overall accuracy.
- Achieved approximately 90% sensitivity and specificity for predicting clusters 2 and 3.
Conclusions:
- Pediatric obstructive sleep apnea syndrome exhibits significant clinical heterogeneity.
- Recognizing distinct clinical profiles can guide more personalized diagnostic and therapeutic approaches.
- This classification aids in tailoring interventions for better patient outcomes.
Objective:
This study aimed to identify the heterogeneity of obstructive sleep apnea syndrome clinical presentation in children.
Participants:
Children who were 3-14 years old and with obstructive sleep apnea syndrome after polysomnography monitoring (apnea and hypopnea index>5 or obstructive apnea index>1) in the sleep center of Beijing Children's Hospital were included.
Methods:
A sleep disorder questionnaire including different combinations of symptoms and co-morbidities of obstructive sleep apnea syndrome in children was used. A cluster analysis was used to classify the data.
Results:
The apnea hypopnea index alone is not adequate to predict clinical phenotypes. Based on symptoms and co-morbidities of obstructive sleep apnea syndrome, three distinct clusters were identified. They were "nocturnal snoring and daytime sleepiness group" (cluster 1), "hyperactivity group" (cluster 2), and "minimally symptomatic group" (cluster 3). A prediction model was built according to eight variables which showed statistical significance by pairwise comparison among clusters. Overall accuracy of the prediction model could reach 86%. Both the sensitivity and specificity of cluster 2 and 3 prediction were around 90%.
Conclusion:
Children with obstructive sleep apnea syndrome have different patterns of clinical presentation and the identification of the different clinical profiles of obstructive sleep apnea syndrome can provide clues for more personalised diagnoses and therapies.
Related Concept Videos
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Sleep Apnea
The condition is more prevalent among...
07:40Multi-Modal Home Sleep Monitoring in Older Adults
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
06:39Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
